SVAS Biosana, meeting resolves disposal of treasury shares and statutory amendments

Svas Biosana 9 month revenues rise to 859 million euros

(Finance) – The Shareholders’ Meeting of Svas Biosanaa leading operator in the healthcare sector listed on Euronext Growth Milan, in ordinary sessionconferred to the Board of Directors the authorization to purchase and dispose of treasury shares for a period of 18 months from today’s meeting, on one or more occasions, up to a maximum number not exceeding 20% โ€‹โ€‹of the share capital and not exceeding 1,000,000 euros.

The Assembly also resolved that treasury share purchase transactions be carried out on the Euronext Growth Milan multilateral trading system at a price that is no more than 15% lower or higher than the reference price recorded by the stock in the last stock market session. preceding each single operation.

In Extraordinary Session, the Assembly resolved to amend article 16 of the Statute social, relating to participation and voting in the Assembly.

tlb-finance